| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |